Benzoyl Peroxide 2.5–10%
Brand names: PanOxyl (2.5%, 5%, 10% gel/wash), Brevoxyl (4% cream), Duac (benzoyl peroxide 5% + clindamycin 1% — combination)
Benzoyl peroxide is a topical agent used for mild-to-moderate acne, available alone and in fixed combinations with antibiotics or retinoids.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It releases oxygen radicals that are bactericidal against Cutibacterium acnes and also has mild keratolytic and comedolytic activity, and importantly reduces the emergence of antibiotic resistance.
Prescribing in practice
- It bleaches hair, clothing, bedding and towels, so warn patients to avoid contact with coloured fabrics and to use white linen.
- Local irritation, dryness and peeling are common; start at a lower strength or reduced frequency and build up to improve tolerability.
- Combining with a topical or oral antibiotic helps limit antibiotic resistance compared with antibiotic monotherapy.
Monitoring
Assess response and skin tolerability clinically; no laboratory monitoring is needed.
Counselling the patient
- Be aware that it can bleach towels, bedding and coloured clothing.
- Expect some dryness and peeling at first, which usually eases with continued use.
- Apply to the whole affected area rather than just individual spots.
Evidence & guidelines
Benzoyl peroxide is recommended in NICE guidance on acne vulgaris as a component of first-line topical treatment regimens.
Reference: BAD Acne Guidelines 2021; NICE CG184; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acne Severity Classification (IGA Scale) · Acne
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Rh(D) Immune Globulin Dosage for Maternal-Fetal Haemorrhage · Haematology in Pregnancy
- AREDS Classification of Age-related Macular Degeneration · Macular Degeneration
- Diabetic Macular Oedema (DMO) Classification · Diabetic Retinopathy
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD